Home » Topics » BioWorld Science

BioWorld Science
RSS

Hypothermia activates hypoxia protein, benefits metabolism

Oct. 30, 2019

Alpha-synuclein and autophagy

Oct. 30, 2019

Clinical development of MOR-106 for atopic dermatitis ended for futility

Oct. 29, 2019

At Molecular Targets meeting, a bonanza of ways to thwart "undruggable" KRAS

Oct. 29, 2019

CARB-X award supports BioVersys' development of antimicrobial therapies

Oct. 29, 2019

AstraZeneca reports promising PFS data with Imfinzi and tremelimumab in stage IV NSCLC

Oct. 29, 2019

European Commission approves Bavencio with axitinib for first-line advanced RCC

Oct. 29, 2019

Ziopharm and MD Anderson agree to expand TCR-T program

Oct. 29, 2019

New adenosine A2A receptor antagonists disclosed by BeiGene

Oct. 29, 2019

Flex Pharma synthesizes voltage-gated sodium channel blockers

Oct. 29, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...